Clicbiotech
1 known investors
ClicBio develops oral small-molecule CLIC1 inhibitors to treat metabolic diseases by modulating appetite through hypothalamic neuron regulation. The company targets obesity and metabolic disease through a mechanism that acts independently from and additively with GLP-1 agonists.
Founders & leadership
JD

John DobakCEO and Co-Founder
JH

Jay HaganBoard Member and Co-Founder
BS

Bruce SteelBoard Member and Co-Founder
OO

Olivia OsbornCo-Founder/Advisor
Investors · 1
Competitors · 1
by search overlapCompanies competing with Clicbiotech for the same Google search keywords, organic and paid, via search-intersection analysis.
Frequently asked questions
- What does Clicbiotech do?
- ClicBio develops oral small-molecule CLIC1 inhibitors to treat metabolic diseases by modulating appetite through hypothalamic neuron regulation. The company targets obesity and metabolic disease through a mechanism that acts independently from and additively with GLP-1 agonists.
- Who founded Clicbiotech?
- Clicbiotech was founded by John Dobak, Jay Hagan, Bruce Steel, Olivia Osborn.
- Who are Clicbiotech's investors?
- Clicbiotech's investors include Medical Excellence Capital.
